GlobeNewsWire
22 Jun 2026, 12:45 UTC · 1h ago
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GlobeNewsWire
22 Jun 2026, 12:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
AIM ImmunoTech CEO Thomas Equels will present in the Webull Corporate Connect Webinar Series on June 24, 2026. — Corporate presentations to retail platforms can increase visibility and liquidity but rarely drive fundamental value shifts.
+0.10Which stocks this story touches
The company is actively promoting its leadership via a webinar and recently achieved a clinical milestone in a Phase 2 study.
The company is mentioned as the host of a corporate webinar series, showcasing its platform's reach.
Continue reading
6 related stories
Search tags
[mutual] AIM ImmunoTech is presenting in a webinar series hosted by Webull Corporation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
14h ago
